Abstract:The symptoms of SARS-CoV-2 infection vary widely, ranging from asymptomatic cases to severe forms marked by acute respiratory distress syndrome, multi-organ damage, and fatalities. Studies indicate a correlation between specific genes and susceptibility to SARS-CoV-2 infection and disease severity, particularly involving variants in genes linked to inflammation and immune responses. The objective of this study is to investigate the association between rs1800795 (− 174 G > C) and rs1800797 (− 597 A > G) variants in the interleukin-6 (IL-6) promoter region and susceptibility to SARS-CoV-2 infection. Additionally, we aim to explore their correlation with COVID-19 severity in a Moroccan population. In this case-control study, we enrolled 270 unvaccinated COVID-19 patients, consisting of 132 with severe COVID-19 and 138 with asymptomatic-moderate COVID-19. Additionally, we included 339 SARS-CoV-2-negative group. Genotyping of rs1800795 and rs1800797 polymorphisms of the IL-6 gene was performed using predesigned TaqMan SNP genotyping. The median age of SARS-CoV-2-negative controls was 50 years, while severe COVID-19 cases exhibited a median age of 61 years. Additionally, individuals with asymptomatic to moderate COVID-19 had a median age of 36 years. We observed a significant age difference between severe and mild COVID-19 patients ( p < 0.0001), and an association was noted between gender and the severity of COVID-19 ( p = 0.011). The allele and genotype frequencies of the IL-6 − 597G > A and − 174G > C variants did not show significant associations with susceptibility to SARS-CoV-2 infection ( p > 0.05). However, further analysis revealed that the linkage disequilibrium between rs1800797 and rs1800795 indicated that individuals with the GC* haplotype (OR = 0.04, 95% CI 0.01–0.30, p = 0.001) and AG* haplotype (OR = 0.11, 95% CI 0.03–0.46, p = 0.002) were significantly associated with protection against SARS-CoV-2 infection. Moreover, in the overdominant model, the IL-6 − 174 G/C genotype was found to be protective against the development of severe disease compared to those with the G/G-C/C genotypes ( p = 0.03; OR = 0.41, 95% CI 0.18–0.96). However, correlations between complete blood count markers, hematological markers, D-dimer, C-reactive protein, and ferritin levels according to − 597 A > G and − 174G > C genotypes showed no significant differences (all p > 0.05). Our findings provide valuable insights into the pathogenesis of COVID-19, suggesting that genetic variations at the IL-6 gene may contribute to the susceptibility to severe SARS-CoV-2 infection within the Moroccan population.

Critically-ill COVID-19 Susceptibility Gene CCR3 Shows Natural Selection in Sub-Saharan Africans

Critically-ill COVID-19 susceptibility gene shows natural selection in sub-Saharan Africans

Regulatory variants of APOBEC3 genes potentially associate with COVID-19 severity in populations with African ancestry

A genetic variant in IL-6 lowering its expression is protective for critical patients with COVID-19

Lineage-specific Positive Selection on ACE2 Contributes to the Genetic Susceptibility of COVID-19.

The Interleukin-6 gene variants may protect against SARS-CoV-2 infection and the severity of COVID-19: a case-control study in a Moroccan population

The Genetic Variation of Ccr5, Cxcr4 and Sdf-1 in Three Chinese Ethnic Populations

Distribution of Three Hiv-1 Resistance-Conferring Polymorphisms (Sdf1-3 ' A, Ccr2-641, and Ccr5-Delta 32) in Global Populations

MAP3K19 regulatory variation in populations with African ancestry may increase COVID-19 severity

Could the CCR5-Δ32 Mutation be Protective in SARS-CoV-2 Infection?

Whole-genome sequencing reveals host factors underlying critical COVID-19

Interleukin-1 Beta rs16944 and rs1143634 and Interleukin-6 Receptor rs12083537 Single Nucleotide Polymorphisms as Potential Predictors of COVID-19 Severity

Host Genetic Impact on Infectious Diseases among Different Ethnic Groups

Single nucleotide variants in the CCL2, OAS1 and DPP9 genes and their association with the severity of COVID-19 in an Ecuadorian population

Genetic mechanisms of critical illness in Covid-19

Human genetic basis of severe or critical illness in COVID-19

Coronavirus Host Genomics Study: South Africa (COVIGen-SA)

Genetic predisposition to blood cell indices in relation to severe COVID‐19

Host Genetic Factors, Comorbidities and the Risk of Severe COVID-19

Host genetic variants regulates CCR5 expression on immune cells: a study in people living with HIV and healthy controls

In COVID-19, NLRP3 inflammasome genetic variants are associated with critical disease and these effects are partly mediated by the sickness symptom complex: a nomothetic network approach